Pharmacoeconomic Analysis of Drug Therapy.

Pharmacoeconomic benefits of antihypertensive therapy.

BACKGROUND Effective blood pressure reduction reduces cardiovascular risk and prevents later complications. OBJECTIVE To consider the pharmacoeconomic benefits of antihypertensive therapy. SUMMARY Every managed care pharmacist should consider the balance of cost and benefit of antihypertensive therapies, ensuring that best treatment options for patients with the lowest cost to the health ca...

Pharmacoeconomic Analysis Of Everolimus Immunosupressive Therapy After Renal Transplantation.

1Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education, Moscow 2Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution, Moscow 3First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation 4Volgograd State Medi...

Pharmacoeconomic considerations in peripheral arterial thrombolytic therapy.

Intraarterial thrombolytic therapy with urokinase (UK) offers documented advantages to alternatives for treating both subacute and the initial presentation of acute peripheral arterial occlusion (PAO), including reduced morbidity and mortality. Treatment with intraarterial UK does not increase overall health care costs; hospital length of stay is either similar to that with other therapies (acu...

A Prescription for Pharmacoeconomic Analysis

Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.

Non-steroidal anti-inflammatory drugs are commonly used to reduce inflammation and pain associated with arthritis. However, non-steroidal anti-inflammatory drugs induce gastrointestinal side-effects such as dyspeptic symptoms, duodenal or gastric ulcers and, in some cases, serious complications. The aim has been to compare the benefits with the drawbacks of non-steroidal anti-inflammatory drug ...